← All companies
BPTH
Bio-Path Holdings, Inc.
$0.04
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$2.01M
Revenue (TTM)
$37.0K
Net income (TTM)
-$8.70M
EPS (TTM)
$-1.09
P/E ratio
—
Dividend yield
—
Free cash flow
-$10.6M
Cash
$12.0K
Total assets
$677K
Gross margin
—
52-week range
$0.01 – $0.14
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure; Other events
Jul 16, 2026
8-K
Regulation FD disclosure; Other events
May 26, 2026
10-Q
Quarter ended 2026-03-31
May 20, 2026
8-K
Amended charter or bylaws; Other events
Mar 20, 2026
8-K
Change in control; Amended charter or bylaws; Regulation FD disclosure; Other events
Feb 24, 2026
10-Q
Quarter ended 2025-09-30
Jan 13, 2026
8-K
Director or officer change; Other events
Nov 14, 2025
8-K
Director or officer change
Oct 29, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Changed accountants
Aug 13, 2025
8-K
Director or officer change; Other events
Jun 24, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Other events
May 2, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Apr 29, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Mar 28, 2025
8-K
Results of operations (earnings release)
Mar 28, 2025
10-K
Fiscal year ended 2024-12-31
Mar 27, 2025
8-K
Regulation FD disclosure
Mar 19, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Mar 7, 2025
8-K
Delisting notice or listing-rule failure
Feb 18, 2025
8-K
Regulation FD disclosure
Jan 10, 2025
8-K
Regulation FD disclosure
Dec 19, 2024
8-K
Delisting notice or listing-rule failure; Director or officer change; Shareholder vote results
Dec 13, 2024
8-K
Regulation FD disclosure
Dec 12, 2024
8-K
Other events
Nov 25, 2024
8-K
Results of operations (earnings release)
Nov 15, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Oct 11, 2024
8-K
Delisting notice or listing-rule failure
Sep 13, 2024
8-K
Regulation FD disclosure
Aug 21, 2024
8-K
Results of operations (earnings release)
Aug 15, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Other events
Jul 11, 2024
8-K
Other events
Jun 14, 2024
8-K
Regulation FD disclosure
Jun 14, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Jun 5, 2024
8-K
Other events
Jun 3, 2024
8-K
Regulation FD disclosure
May 30, 2024
8-K
Results of operations (earnings release)
May 15, 2024
10-Q
Quarter ended 2024-03-31
May 14, 2024